Hims & Hers (HIMS) Stock News: FTC Suit and Class Actions Over Subscriptions and Health Data

The Federal Trade Commission sued Hims & Hers Health on July 29, 2026 in federal court in San Francisco, joined by Los Angeles County on behalf of the People of California and by Utah’s Division of Consumer Protection, according to OpenClassActions. The case is FTC v. Hims & Hers Health (No. 3:26-cv-07871).

What the government alleges#

Hims sells prescription treatments for hair loss, sexual health, weight loss and mental health as subscriptions. The FTC alleges the company’s ads and intake forms led people to be charged for subscriptions they did not knowingly agree to, made cancellation difficult, and shared health information with advertising platforms despite privacy promises.

The private suits#

Doe v. Hims & Hers Health (No. 3:26-cv-07941), filed July 30 in the same court, focuses on data sharing and seeks damages for people whose information went to third parties. A shareholder suit over the stock drop after the FTC announcement was filed September 1. All are unproven complaints; no class is certified, and there is nothing to claim.

Why it matters for the stock#

For readers following HIMS, the subscription-billing allegations go to the core of the business model, and FTC cases of this type have ended with required changes to sign-up and cancellation flows that can affect retention. The company’s response on the docket and any settlement terms with the FTC are the items to watch.

Read the full case page on OpenClassActions.

Published October 21, 2026. Informational reporting, not legal or investment advice. TickerPosts and OpenClassActions.com share a founder. Settlements resolve claims without an admission of wrongdoing, and allegations in pending lawsuits are unproven.